Rheology of paraproteinaemias and the plasma hyperviscosity syndrome (Q39696973)

14 September 2017

1 reference

title

Rheology of paraproteinaemias and the plasma hyperviscosity syndrome (English)

1 reference

14 September 2017

1 reference

Somer T

1

1 reference

14 September 2017

publication date

1 September 1987

1 reference

Best Practice and Research: Clinical Haematology

14 September 2017

published in

1 reference

14 September 2017

volume

1

1 reference

14 September 2017

issue

3

1 reference

14 September 2017

page(s)

695-723

1 reference

Multiple myeloma in a patient with sickel cell anemia. Interacting effects on blood viscosity

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Rheumatoid arthritis with Felty's syndrome, hyperviscosity and immunologic hyperreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Regulation of cerebral blood flow in response to changes in blood viscosity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Aggregation of γG3 proteins: relevance to the hyperviscosity syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Anemia in macroglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Evaluation of hyperviscosity in monoclonal gammopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

On the aggregation of red cells in Waldenström's macroglobulinaemia and multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

A hypothesis of plasma "atomosphere" around the red cells in patients with Waldenström's macroglobulinemia and multiple myeloma: A deduction from viscosity study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Plasmapheresis in paraproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

SERUM PROTEIN DISORDERS CAUSING CLINICAL SYMPTOMS IN MALIGNANT NEOPLASTIC DISEASE

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

SERUM HYPERVISCOSITY SYNDROME

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Ocular manifestations of hematologic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Polyclonal hyperviscosity syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Immunochemical classes of myelomatosis. Including data from a therapeutic trial conducted by a Medical Research Council working party

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Mortality in therapeutic haemapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Experience with Large Volume Plasmapheresis in Malignant Paraproteinemia and Immune Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Rheumatoid hyperviscosity syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Intensive Plasma Exchange on the Cell Separator: Effects on Serum Immunoglobulins and Complement Components

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Coagulation Abnormalities Produced by Plasma Exchange on the Cell Separator with Special Reference to Fibrinogen and Platelet Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Hyperviscosity syndrome associated with an idiopathic monoclonal IgA-rheumatoid factor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

[Paraproteinaemic coma in multiple myeloma (author's transl)]

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Hyperviscosity syndrome in multiple myeloma. A reversible, concentration-dependent aggregation of the myeloma protein

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Blood rheology in arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Retinal Circulation in the Hyperviscosity Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Paraproteinemia: blood hyperviscosity and clinical manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

The hyperviscosity syndrome. I. In IgG myeloma. The role of protein concentration and molecular shape

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Leukocytoclastic vasculitis in association with immunoglobulin A myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Hyperviscosity-induced dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Pseudohyponatremia and hyperviscosity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Clinical aspects of IgE myeloma.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Paraprotein-induced hyperviscosity. A reversible cause of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Plasma exchange and moderate dose of cytostatics in advanced macro(cryo)globulinemia. A report on three cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Rheumatoid Arthritis Associated With Hyperviscosity Syndrome and Intermediate Complex Formation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Method of Removing Abnormal Protein Rapidly from Patients with Malignant Paraproteinaemias

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Myelomatosis and the Hyperviscosity Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Hyperviscosity syndrome in IgE myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Serum viscosity and hyperviscosity syndrome in IgG multiple myeloma — the relationship to Sia test and to concentration of M component

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Serum viscosity and hyperviscosity syndrome in IgG multiple myeloma. Report on 10 patients and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Efficient removal of abnormal immunoglobulin G from plasma of a multiple myeloma patient. Description of a new method for treatment of the hyperviscosity syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Relationship between paraprotein polymerization and clinical features in IgA myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Polymeric IgA myeloma, hyperlipidaemia and xanthomatosis: a further case and review

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

The relationship between serum viscosity, hypervolaemia and clinical manifestations associated with circulating paraprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Red cell aggregation in blood flow. I. New methods of quantification

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Red cell aggregation in blood flow. II. Effect on apparent viscosity of blood

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

[Hemorrheological changes in 50 monoclonal dysglobulinemias treated by plasma exchange]

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

IgG subclasses: relationship to clinical aspects of multiple myeloma and frequency distribution among M-components

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Treatment of Waldenstrom's macroglobulinemia by plasmapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Reversal of retinopathy in Waldenstrom's macroglobulinemia by plasmapheresis. A report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Therapeutic Plasma Exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

AGGREGATION OF IGG GLOBULIN IN VIVO. I. THE HYPERVISCOSITY SYNDROME IN MULTIPLE MYELOMA

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Plasmapheresis therapy in macroglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

1 reference

7 January 2021

Irreversible visual loss in Waldenström's macroglobulinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Hyperviscosity syndrome in IgA multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Management of Immune-Mediated and Paraproteinemic Diseases by Membrane Plasma Separation and Cascade Filtration

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Polymerized Monoclonal IgA in Two Patients with Myelomatosis and Hyperviscosity Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Incipient myelomatosis or «essential« hyperglobulinemia with fibrinogenopenia - a new syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Plasmapheresis and cold sensitivity of immunoglobulin molecules. I. A study of hyperviscosity, cryoglobulinemia, euglobulinemia and macroglobulinemia vera

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

Syndromes of Hyperviscosity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

The complications of therapeutic plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980021-5

7 January 2021

10.1016/S0950-3536(87)80021-5

Identifiers

DOI

1 reference

14 September 2017

1 reference